Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Jo Natauri Biography and Net Worth

Director of Avantor

Jo Natauri has served as a member of our board of directors since November 2020. Ms. Natauri is a Managing Director and the global head of Healthcare Investing within the Merchant Banking Division (MBD) of Goldman Sachs, a global investment banking, securities and investment management firm, a position she has held since May 2018. In her current role, Ms. Natauri oversees a portfolio of investments and serves on the boards, or as an observer on the boards, of several MBD portfolio companies. Prior to assuming her current role at MBD, Ms. Natauri was an investment banker with Goldman Sachs for 12 years, where she led coverage of large cap companies in healthcare and other industries. She was named managing director in 2008 and partner in 2012. Ms. Natauri serves on the board of Safe Horizon, the nation’s leading victim assistance organization. Ms. Natauri earned a Bachelor of Arts in economics and biology from the University of Virginia.

What is Jo Natauri's net worth?: The estimated net worth of Jo Natauri is at least $22.26 million as of December 12th, 2022. Ms. Natauri owns 1,070,982 shares of Avantor stock worth more than $22,255,006 as of November 22nd. This net worth approximation does not reflect any other investments that Ms. Natauri may own. Learn More about Jo Natauri's net worth.
How do I contact Jo Natauri?: The corporate mailing address for Ms. Natauri and other Avantor executives is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. Avantor can also be reached via phone at (610) 386-1700 and via email at [email protected]. Learn More on Jo Natauri's contact information.
Has Jo Natauri been buying or selling shares of Avantor?: Jo Natauri has not been actively trading shares of Avantor during the past quarter. Most recently, on Monday, July 12th, Jo Natauri bought 300 shares of Avantor stock. The stock was acquired at an average cost of $36.33 per share, with a total value of $10,899.00. Following the completion of the transaction, the director now directly owns 92,661 shares of the company's stock, valued at $3,366,374.13. Learn More on Jo Natauri's trading history.
Who are Avantor's active insiders?: Avantor's insider roster includes James Bramwell (EVP), Gerard Brophy (EVP), Christophe Couturier (EVP), Steven Eck (CAO), Rajiv Gupta (Director), Justin Miller (EVP), Jo Natauri (Director), Devashish Ohri (EVP), Christi Shaw (Director), Michael Stubblefield (CEO), Thomas Szlosek (CFO), Frederic Vanderhaegen (EVP), and Michael Wondrasch (EVP). Learn More on Avantor's active insiders.
Are insiders buying or selling shares of Avantor?: In the last twelve months, insiders at the sold shares 2 times. They sold a total of 9,728 shares worth more than $240,247.97. The most recent insider tranaction occured on September, 5th when CAO Steven W Eck sold 3,525 shares worth more than $88,336.50. Insiders at Avantor own 1.5% of the company. Learn More about insider trades at Avantor.
Information on this page was last updated on 9/5/2024.

Jo Natauri Insider Trading History at Avantor

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/12/2021	Buy	300	$36.33	$10,899.00	92,661
5/11/2021	Sell	2,626,771	$30.68	$80,589,334.28	92,661
8/21/2020	Sell	15,397,005	$19.51	$300,395,567.55
5/26/2020	Sell	13,726,411	$15.90	$218,249,934.90

Jo Natauri Buying and Selling Activity at Avantor

Avantor Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Today's Range

Now: $20.78

$20.25

$20.85

50 Day Range

MA: $24.01

$19.72

$27.70

2 Week Range

Now: $20.78

$19.59

$28.00

Volume

7,456,697 shs

Average Volume

6,501,795 shs

Market Capitalization

$14.14 billion

P/E Ratio

45.17

Dividend Yield

N/A

Beta

1.35

Let’s be blunt

From DTI | Ad

Check out the $100 Challenge now